Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Graduate Research Explores Glioblastoma Tumor Cells Invasion in 3D Environments

January 11, 2017 By Wichita State University

Since she was 7, graduate student Pranita Kaphle has wanted to make a difference in the field of cancer research. Attending graduate school at Wichita State University has allowed her to do just that.

She was inspired to find a treatment after losing an aunt to cancer, and the high death rate of glioblastoma cancer continues to motivate her.

“Many scientists and researchers are doing research on these tumor cells because they’re very aggressive and invasive,” says Kaphle. “What distinguishes my research from others’ is I’m using a 3D culture that mimics our body, and my process is entirely different.”

WSU graduate student Pranita Kaphle uses 3D cultures to research glioblastoma multiforme’s migration through the brain. (Credit: Wichita State University)

Glioblastoma multiforme (GBM), also known as grade IV astrocytoma, is an extremely rapid-spreading and aggressive tumor commonly found in the central nervous system. It typically arises from supportive cells found in the brain.

Glioblastoma is the most common type of brain tumor and is often associated with a poor prognosis and high mortality rate. The likelihood of developing this tumor increases with age and is most commonly found in adults 45-65 years old. According to the American Brain Tumor Association, the average survival time following diagnosis is only 14 months.

Although there are many treatments available for GBM, including surgical removal, chemotherapy and radiation, the prognosis remains poor and quality of life diminishes.

“If I will be able to use an inhibitor to block the cancer cell invasion, it could be a therapeutic target of glioblastoma multiforme,” says Kaphle.

Kaphle is creating an innovative lab test that will allow her to test highly invasive cancer cells in a 3D environment, showing an accurate model of how these cells invade in the brain.

Studying with Li Yao, assistant professor of biological sciences, Kaphle is using a hydrogel to study the process of tumor invasion. She’s looking for a way to inhibit the rapid spread of the cancer cells.

“There are many different molecules that play a role in the migration of the cancer cells,” she says. “I’m targeting different molecules, using different types of inhibitors to stop their pathways.”

Kaphle began her studies in Nepal, but was in search of a university doing more in the area of cancer cell research. She heard about Wichita State from friends and began looking into the research going on here. She was thrilled to find there were WSU professors researching glioblastoma cells and applied to transfer.

Kaphle has found this support outside of the classroom as well, which she says is extremely helpful in her success as an international student.

She will graduate in December 2017 with a master’s degree in biological science and plans to continue her research with the glioblastoma cells.

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech